Overview A Vasoconstriction Study With LEO 90100 Status: Completed Trial end date: 2013-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the pharmacodynamic activity of LEO 90100 with Dermovate® cream, Dovobet® ointment, betamethasone dipropionate in LEO90100 vehicle, Synalar® ointment and LEO 90100 vehicle using a human skin blanching test. Phase: Phase 1 Details Lead Sponsor: LEO PharmaTreatments: BetamethasoneBetamethasone benzoateBetamethasone sodium phosphateBetamethasone ValerateBetamethasone-17,21-dipropionateClobetasol